Calendar of Events Donate Now
Subscribe for Email Updates

    I wish all people with MS could attend a CAN DO Program. I doubt there is anything, anywhere that even comes close to the quality and quantity of information and concern that was displayed. Thank you very much!

    CAN DO Program Participant
    •  

    Pharmaceutical Transparency


    Can Do MS’s programs enhance and complement traditional models of care by focusing on the physical, interpersonal, emotional, intellectual and spiritual aspects of living with MS. We believe that pharmaceutical therapies are one part of the overall care plan for people living with multiple sclerosis. We work to educate those with MS, as well as medical and pharmaceutical professionals, on our whole-person, whole-health, whole-community philosophy to maximizing health and living with MS.

    Can Do MS’s Position Regarding Its Relationship with the Pharmaceutical Industry
    Many pharmaceutical companies recognize that our programs can complement the therapies they offer.  When grant or sponsorship funds are provided by pharmaceutical companies to help support our programs that require outside funding, such as CAN DO® Program, JUMPSTART® Program, TAKE CHARGE™ Program, Webinar Series and other online resources, pharmaceutical companies do not have input into the content of these programs or direct how these funds will be spent in the service of our mission.

    In 2013 Can Do MS’s total revenue was $1,516,859; below is a breakdown of pharmaceutical contributions included in this.

    2013 Pharmaceutical Contribution:

    • Total Pharmaceutical Revenue: $727,076
    • Percentage of Total Organizational Revenue: 48%
    • Event Sponsorship: $302,000
    • Program Grants: $425,076

    Contributions by companies without an MS product on market in 2013:

    • Genentech, Inc.: $121,000

    Contributions by companies with an MS product on market in 2013:

    • Acorda Therapeutics, Inc.: $116,304
    • Allergan, Inc.: $5,000
    • Biogen Idec: $21,500
    • Bioness: $2,500
    • EMD Serono, Inc.: $65,000
    • Genzyme Corporation: $155,272
    • Novartis Pharmaceuticals Corp.: $100,000
    • Pfizer Inc.: $8,500
    • Questcor Pharmaceuticals, Inc.: $10,000
    • Teva Neuroscience: $122,000
    100 W. Beaver Creek Blvd. Suite 200 PO Box 5860 Avon, CO 81620 Phone: 970-926-1290 or 800-367-3101 Fax: 970-926-1295 Email: info@mscando.org
    MS Coalition Charity Navigator Consortium of Multiple Sclerosis Centers Independent Charities of America Humane Charity

    Can Do Multiple Sclerosis™ is a 501 (c)(3) nonprofit organization.
    Charitable Organization Number: 74-2337853

    Formerly The Heuga Center for Multiple Sclerosis | Founded by Jimmie Heuga

    A national nonprofit organization, Can Do MS is a leading provider of innovative lifestyle empowerment programs
    that empower people with MS and their support partners to transform and improve their quality of life.

    Donate to Can Do MS on December 9th for Colorado Gives Day and watch your donation go further! - Read More